Abe Shun, Sakata Jun, Miura Kohei, Saito Seiji, Nagaro Hiroki, Miura Yohei, Ando Takuya, Ishikawa Hirosuke, Takizawa Kazuyasu, Muneoka Yusuke, Tajima Yosuke, Ichikawa Hiroshi, Shimada Yoshifumi, Kobayashi Takashi, Wakai Toshifumi
Division of Digestive and General Surgery, Niigata University Graduate School of Medical and Dental Sciences.
Gan To Kagaku Ryoho. 2023 Feb;50(2):227-229.
We report a case of intrahepatic cholangiocarcinoma(ICC)with lymph node metastases in which long-term survival was achieved after surgery followed by chemotherapy. A 69-year-old man underwent left hepatectomy, extrahepatic bile duct resection, and lymph node dissection for ICC located mainly in segment 4 of the liver with enlarged lymph nodes in the hepatoduodenal ligament. The histopathologically confirmed diagnosis was ICC(T2N1M0, Stage ⅣA)with 3 positive lymph nodes(No. 12a1, No. 12p1, and No. 12p2). He received chemotherapy with gemcitabine(GEM)plus cisplatin(CDDP)for 9 months, followed by GEM monotherapy for 4 months, and then S-1 monotherapy was started. A right lung nodule was detected 12 months after the initiation of S-1 monotherapy. He received GEM plus S-1 therapy for 28 months, followed by S-1 monotherapy, leading to disappearance of the lung nodule. He remains alive and well without disease 78 months after surgery. Our experience in this case suggests that radical resection followed by chemotherapy may provide a survival benefit in selected patients who have ICC with nodal disease.
我们报告了一例肝内胆管癌(ICC)伴淋巴结转移的病例,该患者在手术及化疗后实现了长期生存。一名69岁男性因主要位于肝4段且肝十二指肠韧带淋巴结肿大的ICC接受了左肝切除、肝外胆管切除及淋巴结清扫术。组织病理学确诊为ICC(T2N1M0,ⅣA期),有3个阳性淋巴结(第12a1、12p1和12p2组)。他接受了9个月的吉西他滨(GEM)联合顺铂(CDDP)化疗,随后4个月接受GEM单药治疗,然后开始S-1单药治疗。在开始S-1单药治疗12个月后检测到右肺结节。他接受了28个月的GEM联合S-1治疗,随后接受S-1单药治疗,肺结节消失。术后78个月,他仍存活且无疾病。我们在该病例中的经验表明,对于某些伴有淋巴结转移的ICC患者,根治性切除后进行化疗可能会带来生存益处。